Relay Therapeutics, Inc. RLAY Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$73.29M-33.5% | -$54.89M+26.0% | -$74.15M-5.4% | -$70.38M+8.7% | -$77.07M-1.4% | ||
| $504K-15.9% | $599K-19.9% | $748K-25.3% | $1M-17.1% | $1.21M-9.4% | ||
| $10.54M-19.4% | $13.07M-15.8% | $15.53M+7.1% | $14.5M-25.0% | $19.33M+9.6% | ||
| -$51.11M-13.9% | -$44.87M+27.8% | -$62.12M-12.4% | -$55.26M+24.5% | -$73.21M-26.5% | ||
| —— | $1K— | $0-100% | $26K-93.2% | $384K— | ||
| $32.9M-7.2% | $35.46M-10.7% | $39.73M-47.1% | $75.15M+77.0% | $42.47M— | ||
| $138.78M+14,759% | $934K+5,394% | $17K— | —— | —— | ||
| $120.57M+1,524% | -$8.47M+62.2% | -$22.38M— | —— | -$30.75M-9.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Relay Therapeutics, Inc. generate?
- Relay Therapeutics, Inc. (RLAY) generated -$213.4M in operating cash flow over the trailing twelve months.
- Where does Relay Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Relay Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
